Story thread · 3 reports / 3 sources
FDA scientists question Capricor data; Legend CEO steps down
biopharmadive.com · 15d
How the coverage leans
Across 3 sources · syndicated copies counted once
Capricor shares lost much of their value ahead of a high-stakes advisory committee meeting. Elsewhere, Ying Huang’s resignation extended a stock slide for Legend and AstraZeneca disclosed more pipeline trouble.
First report: Legend Biotech CEO Ying Huang steps down — seekingalpha.com, 15d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.